Stay updated with breaking news from Jupiter Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caas Capital Management LP cut its stake in shares of Jupiter Acquisition Co. (NASDAQ:JAQC – Free Report) by 75.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 235,638 shares of the company’s stock after selling 706,912 shares during the quarter. Jupiter Acquisition accounts […]
Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announced the signing of a non-binding term sheet for potential funding of up to...
Periscope Capital Inc. purchased a new position in shares of Jupiter Acquisition Co. (NASDAQ:JAQC – Free Report) during the 1st quarter, HoldingsChannel reports. The institutional investor purchased 126,353 shares of the company’s stock, valued at approximately $1,276,000. Other institutional investors have also added to or reduced their stakes in the company. UBS Group AG purchased […]
VANCOUVER, BC, Aug. 15, 2023 /CNW/ - Filament Health Corp. , a clinical-stage natural psychedelic drug development company, released its first quarter financial results and operational highlights... -Today at 07:26 am- MarketScreener
Natural psychedelic drug development company Filament Health (OTCQB: FLHLF) has released its unaudited consolidated, condensed financial results for Q1 2023 ended June 30. Numbers show: